KeyBanc analyst Paul Knight raised the price target on Exagen (NASDAQ: XGN) to $15.00 (from $12.00) while maintaining a Overweight ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE